<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Live Tuition Academy | Maurizio Chiriva Internati | Activity</title>
	<link>https://livetuitionacademy.com/members/mauriziochirivainternati9/activity/</link>
	<atom:link href="https://livetuitionacademy.com/members/mauriziochirivainternati9/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Maurizio Chiriva Internati.</description>
	<lastBuildDate>Sat, 11 Apr 2026 21:45:42 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=11.4.0</generator>
	<language>en</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">ef1a5e64eeb5ed5081f546bdf156d3ca</guid>
				<title>Maurizio Chiriva Internati posted an update: In the dynamic landscape of biotechnology, the journey of a [&#133;]</title>
				<link>https://livetuitionacademy.com/activity/p/47062/</link>
				<pubDate>Tue, 24 Feb 2026 11:49:19 +0000</pubDate>

									<content:encoded><![CDATA[<p>In the dynamic landscape of biotechnology, the journey of a cancer researcher often merges with tales of both triumph and setback. The path to breakthroughs in oncology is not just about revolutionary advancements in areas like AI-driven immunotherapies or the development of therapeutic platforms targeting tumor-associated antigens. It is also&hellip;<span class="activity-read-more" id="activity-read-more-47062"><a href="https://livetuitionacademy.com/activity/p/47062/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">ecae96428c6240e78aba69bfd5972ed7</guid>
				<title>Maurizio Chiriva Internati posted an update: Wonder has been a driving factor in my journey through the [&#133;]</title>
				<link>https://livetuitionacademy.com/activity/p/47061/</link>
				<pubDate>Tue, 24 Feb 2026 11:42:53 +0000</pubDate>

									<content:encoded><![CDATA[<p>Wonder has been a driving factor in my journey through the detailed world of cancer research and biomedical technology. From the prestigious environments of the MD Anderson facility to the vibrant landscape of emerging companies focused on artificial intelligence-based immune therapies, my background have influenced not only my career but also my&hellip;<span class="activity-read-more" id="activity-read-more-47061"><a href="https://livetuitionacademy.com/activity/p/47061/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">d16016be0e1ba1f7474f7d20febe507b</guid>
				<title>Maurizio Chiriva Internati posted an update: Within the quickly shifting landscape of oncology research [&#133;]</title>
				<link>https://livetuitionacademy.com/activity/p/47060/</link>
				<pubDate>Tue, 24 Feb 2026 11:23:37 +0000</pubDate>

									<content:encoded><![CDATA[<p>Within the quickly shifting landscape of oncology research and biotech, the role of learning and guidance has become increasingly vital. With the next generation of creators arises, they stand on the shoulders of giants, drawing from the experiences and insights of seasoned experts in the field. The transformative potential of cancer treatment has&hellip;<span class="activity-read-more" id="activity-read-more-47060"><a href="https://livetuitionacademy.com/activity/p/47060/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">f47589329f9a11472450179988c98db4</guid>
				<title>Maurizio Chiriva Internati posted an update: Within the ever-evolving landscape of cancer care, Diamond [&#133;]</title>
				<link>https://livetuitionacademy.com/activity/p/47059/</link>
				<pubDate>Tue, 24 Feb 2026 11:16:02 +0000</pubDate>

									<content:encoded><![CDATA[<p>Within the ever-evolving landscape of cancer care, Diamond CancerSplice stands at the forefront of advancement, leading a fresh era in immune therapy that leverages cutting-edge technology and research. This biotechnology startup, emerging from the vision of a committed cancer researcher and biotech innovator, embodies the potential of&hellip;<span class="activity-read-more" id="activity-read-more-47059"><a href="https://livetuitionacademy.com/activity/p/47059/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">87138bdab6604b4f32de2b9430f29257</guid>
				<title>Maurizio Chiriva Internati became a registered member</title>
				<link>https://livetuitionacademy.com/activity/p/47057/</link>
				<pubDate>Tue, 24 Feb 2026 10:46:06 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>